Compare IDEXX Laboratories, Inc. (IDXX) vs Keysight Technologies Inc (KEYS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Keysight Technologies Inc — how do they compare? IDEXX Laboratories, Inc. trades at $573.36 (market cap $46.22B), while Keysight Technologies Inc trades at $354.74 (market cap $58.74B). The key difference: Keysight Technologies Inc is the larger of the two by market cap, and Keysight Technologies Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | KEYS | |
|---|---|---|
Market Cap | $46.22B | $58.74B |
Sector | Health | Technology |
52-Week High | $766.68 | $373.34 |
52-Week Low | $526.44 | $158.51 |
Enterprise Value | $47.12B | $59.08B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $571.44, down 4.08% over the past day, amid a mixed technical and strong fundamental backdrop. The stock shows a bullish trend in moving averages but overbought RSI readings near 73. Recent Q2 2026 earnings beat expectations with 9% organic revenue growth, and the company raised full-year EPS guidance. Profitability remains robust with a 25.03% net income margin and 74.21% ROE.
The outlook is positive given strong earnings momentum, high analyst buy ratings, and a consensus price target of $683.33 implying ~20% upside. Risks include premium valuation multiples and potential market volatility. The stock presents a growth opportunity supported by durable competitive advantages in veterinary diagnostics.
Keysight Technologies (KEYS) trades at $353.23, up 5.31% over the past day and showing strong momentum. The stock is in a bullish technical trend, with recent earnings consistently beating estimates. Revenue for 2025 was $5.38 billion, with a net income margin of 17.31%, and the company has announced strategic collaborations and product launches in 2026, including advancements in 5G and photonics design.
The outlook for KEYS is positive, supported by robust earnings performance and analyst optimism, with an average price target of $396.56. Key risks include high valuation multiples and significant capital expenditure trends. Upside potential hinges on continued execution and market adoption of new technologies.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Keysight Technologies Inc
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →
